Discover how PDZK1 protein sensitizes Triple-Negative Breast Cancer cells to erlotinib by promoting EGFR degradation and inhibiting phosphorylation.
Discover how CAP70 protein offers new hope in treating aggressive triple-negative breast cancer by targeting EGFR pathways with precision biology.